Naya Biosciences Inc (NAYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAYA | AMGN | BMY | VRTX | GILD |
| Company | Naya Biosciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.9040 | 289.84 | 58.35 | 454.30 | 89.81 |
| High | 0.9040 | 291.50 | 58.35 | 456.14 | 90.06 |
| Low | 0.8600 | 288.78 | 57.62 | 449.97 | 89.27 |
| Last | 0.8600 | 291.03 | 58.20 | 453.44 | 89.57 |
| Change | -0.0150 | +1.13 | -0.03 | +3.07 | -0.19 |
| % Change | -1.71% | +0.39% | -0.05% | +0.68% | -0.21% |
| Volume | 2,321 | 92,011 | 459,361 | 89,616 | 147,383 |
| 20-Day Average Volume | 72,281 | 2,847,236 | 12,064,968 | 1,299,281 | 7,249,764 |
| Previous Close | 0.8750 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8294 | 306.14 | 56.23 | 478.08 | 90.94 |
| 20-Day Raw Stochastic | 64.59% | 30.15% | 66.99% | 12.65% | 30.11% |
| 20-Day Relative Strength | 52.03% | 37.76% | 59.97% | 42.55% | 53.98% |
| Weighted Alpha | -61.28 | +2.67 | +25.43 | +19.57 | +26.42 |
| Today's Opinion | 8% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 8% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 8% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.18% since 11/15/24 | +2.76% since 11/15/24 | +3.20% since 11/15/24 | -2.41% since 11/15/24 | +1.74% since 11/15/24 |
| Low | 0.8093 on 11/19/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.9350 on 11/21/24 | 291.50 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.06 on 11/22/24 |
| 1-Month | |||||
| %Chg | -15.69% since 10/22/24 | -8.83% since 10/22/24 | +9.97% since 10/22/24 | -4.30% since 10/22/24 | +2.02% since 10/22/24 |
| Low | 0.7232 on 10/30/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.9690 on 10/23/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +4.61% since 08/22/24 | -10.19% since 08/22/24 | +21.84% since 08/22/24 | -5.30% since 08/22/24 | +18.50% since 08/22/24 |
| Low | 0.6311 on 10/11/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 1.4200 on 10/14/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -5.90% since 05/22/24 | -5.81% since 05/22/24 | +37.03% since 05/22/24 | +1.55% since 05/22/24 | +32.65% since 05/22/24 |
| Low | 0.6311 on 10/11/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.4200 on 10/14/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,319 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 4,936 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 3,020,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -8,030,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 1,840,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,250,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.41 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 11/19/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/25/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |